Abstract |
Use of phencyclidine (PCP) in rodents can mimic some aspects of schizophrenia. However, the underlying mechanism is still unclear. Growing evidence indicates that neuroinflammation plays a significant role in the pathophysiology of schizophrenia. In this study, we focused on inflammatory responses as target of PCP for inducing schizophrenia-like symptoms. 3-month-old C57BL/6J mice received daily injections of PCP (20 mg/kg, i.p.) or saline for one week. PCP-injected mice produced schizophrenia-like behaviours including impaired spatial short-term memory assessed by the Y-maze task and sensorimotor gating deficits in a prepulse inhibition task. Simultaneously, chronic PCP administration induced astrocyte and microglial activation in both the cortex and hippocampus. Additionally, the proinflammatory cytokine interleukin-1β was significantly up-regulated in PCP administrated mice. Furthermore, PCP treatment decreased ratio of the phospho-Ser9 epitope of glycogen synthase kinase-3β (GSK3β) over total GSK3β, which is indicative of increased GSK3β activity. These data demonstrate that chronic PCP in mouse produces inflammatory responses and GSK3β activation.
|
Authors | Shenghua Zhu, Hongxing Wang, Ruoyang Shi, Ruiguo Zhang, Junhui Wang, Lynda Kong, Yingxia Sun, Jue He, Jiming Kong, Jun-Feng Wang, Xin-Min Li |
Journal | Neurochemical research
(Neurochem Res)
Vol. 39
Issue 12
Pg. 2385-93
(Dec 2014)
ISSN: 1573-6903 [Electronic] United States |
PMID | 25270429
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Glycogen Synthase Kinase 3 beta
- Gsk3b protein, mouse
- Glycogen Synthase Kinase 3
- Phencyclidine
|
Topics |
- Animals
- Enzyme Activation
- Glycogen Synthase Kinase 3
(metabolism)
- Glycogen Synthase Kinase 3 beta
- Inflammation
(chemically induced)
- Mice
- Phencyclidine
(toxicity)
|